Skip to content

A randomized control trial for combined proximal femur intramedullary nail and lateral wall plate for the treatment of pantrochanteric fracture

A randomized control trial for combined proximal femur intramedullary nail and lateral wall plate for the treatment of pantrochanteric fracture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025588
Enrollment
Unknown
Registered
2019-09-02
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pantrochanteric fracture

Interventions

Experimental group:Nail + lateral plate
Control Group:Nail

Sponsors

Beijing Luhe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged >=60 years old male and female; (2) Diagnosis of internal and external unstable femoral intertrochanteric fractures (Babhulkar modified type B and C fractures); (3) The patient is undergoing surgery in our hospital; (4) Sign the informed consent form for this study.

Exclusion criteria

Exclusion criteria: (1) severe osteoarthritis, rheumatism or rheumatoid arthritis or pathological fractures; (2) combined with severe injury to the lower extremities (such as the ipsilateral or contralateral foot, tibia, knee or femoral fracture; combined with the lower extremity of the ankle, knee, hip dislocation; combined with femoral head fracture); (3) combined with soft tissue or bone infection of the hip; (4) Combined with metabolic bone diseases other than osteoporosis (such as Paget bone disease, renal bone atrophy, osteomalacia; (5) merging moderate to severe cognitive impairment; (6) Severe Alzheimer's disease and Parkinson's disease can significantly affect walking ability, which is not conducive to postoperative rehabilitation; (7) The patient or his or her family does not agree to participate in the study.

Design outcomes

Primary

MeasureTime frame
Failure rate of implants;Fracture associated complications;

Secondary

MeasureTime frame
Operative time;Blood loss during surgery;Length of hospital stay;Medical complications;VAS score;Harris score;

Countries

China

Contacts

Public ContactLong Anhua

Beijing Luhe hospital, Capital Medical University

nankaims@163.com+86 18911123487

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026